Print

HVTN 703 AMP

NCT02568215

Trial Details:

IIb Ongoing
National Institute of Allergy and Infectious Diseases (NIAID)
VRC-HIVMAB060-00-AB
High-risk healthy women
RandD/trials/Lists/ClinicalTrialsList
10/1/2021
VRC01 Antibody
10 mg/kg or 30 mg/kg  at Weeks 0, 8, 16, 24, 32, 40, 48, 56, 64, and 72.